Forma Therapeutics Holdings, Inc.
DelistedCIK 1538927fmd_15330XSX4SNRZM09ASNNWW85NDManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2019 to Jun 30, 2022, 14 periods
| Line item | FY2019 | FY2020 | FY2021 |
|---|---|---|---|
| Total revenues | 101 | 0 | 0 |
| Research and development | 111 | 93 | 126 |
| Total operating expenses | 141 | 124 | 174 |
| Operating income | (40) | (124) | (174) |
| Interest and investment income | 3 | 3 | 1 |
| Other non-operating income (expense) | 4 | 24 | 1 |
| Income before taxes | (37) | (100) | (173) |
| Income tax expense | (2) | 30 | 0 |
| Net income from continuing operations | (35) | (130) | (173) |
| Net income | (35) | (70) | (173) |
| Net income to common shareholders | (53) | (74) | – |